Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial
Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.

Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page has removed detailed information about the objectives, inclusion and exclusion criteria, and study design for a clinical trial on SAR442168 for relapsing forms of multiple sclerosis, while adding a new registry identifier and a version revision number.SummaryDifference22%
- Check36 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check44 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check80 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check94 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.